Projected Income Statement: Ipsen

Forecast Balance Sheet: Ipsen

Forecast Balance Sheet - Ipsen
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 138 -385 -52.9 -135 -545 -1,508 -2,496 -3,539
Change - -378.99% 86.26% -155.2% -303.7% -176.95% -65.52% -41.79%
Announcement Date 11/02/22 09/02/23 08/02/24 13/02/25 12/02/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Ipsen

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 96 96.6 116.2 173 105.3 114.8 134.2 141.1
Change - 0.62% 20.29% 48.88% -39.13% 8.98% 16.91% 5.17%
Free Cash Flow (FCF) 1 813.2 874.8 710.9 774.4 1,033 1,232 1,246 1,267
Change - 7.58% -18.74% 8.93% 33.41% 19.21% 1.15% 1.74%
Announcement Date 11/02/22 09/02/23 08/02/24 13/02/25 12/02/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Ipsen

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 40.64% 44.57% 28.18% 35.28% 35.21% 43.87% 39.3% 37.91%
EBIT Margin (%) 35.25% 36.87% 32.01% 32.62% 32.94% 37.46% 32.85% 30.96%
EBT Margin (%) 28.39% 23.34% 24.35% 12.69% 14.73% 33.42% 29.48% 26.74%
Net margin (%) 22.54% 21.4% 20.69% 10.21% 11.31% 24.87% 22.16% 20.86%
FCF margin (%) 28.35% 28.92% 22.73% 22.77% 26.29% 26.78% 26.25% 26.1%
FCF / Net Income (%) 125.77% 135.1% 109.84% 222.98% 232.42% 107.67% 118.43% 125.11%

Profitability

        
ROA 13.88% 16.46% 12.83% 13.44% 15.09% 15.58% 13.43% 11.59%
ROE 26.49% 28.73% 21.36% 21.43% 23.69% 25.22% 19.23% 16.19%

Financial Health

        
Leverage (Debt/EBITDA) 0.12x - - - - - - -
Debt / Free cash flow 0.17x - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 3.35% 3.19% 3.72% 5.09% 2.68% 2.49% 2.83% 2.91%
CAPEX / EBITDA (%) 8.23% 7.16% 13.18% 14.42% 7.61% 5.69% 7.19% 7.66%
CAPEX / FCF (%) 11.81% 11.04% 16.35% 22.34% 10.19% 9.32% 10.77% 11.13%

Items per share

        
Cash flow per share 1 10.91 11.72 10.39 10.94 13.65 21.91 17.58 17.52
Change - 7.38% -11.36% 5.33% 24.81% 60.48% -19.75% -0.36%
Dividend per Share 1 1.2 1.2 1.2 1.4 1.4 1.431 1.553 1.447
Change - 0% 0% 16.67% 0% 2.24% 8.52% -6.84%
Book Value Per Share 1 33.33 - 45.64 49.89 51.73 59.88 70.93 81.85
Change - - - 9.32% 3.69% 15.74% 18.45% 15.4%
EPS 1 7.76 7.81 7.73 4.15 5.32 13.75 12.18 11.64
Change - 0.64% -1.02% -46.31% 28.19% 158.43% -11.4% -4.41%
Nbr of stocks (in thousands) 82,243 82,380 82,599 82,700 82,100 81,990 81,990 81,990
Announcement Date 11/02/22 09/02/23 08/02/24 13/02/25 12/02/26 - - -
1EUR
Estimates
2026 *2027 *
P/E 11.1x 12.6x
PBR 2.56x 2.16x
EV / Sales 2.4x 2.12x
Yield 0.93% 1.01%

EPS & Dividend

EPS & Dividend - Ipsen


Y-o-Y evolution of P/E

Valuation ratios - P/E - Ipsen
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Ipsen
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Ipsen
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
153.20EUR
Average target price
161.92EUR
Spread / Average Target
+5.69%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ipsen